TrusCreen Annual Meeting – Withdrawal of Nomination

NZX and Media Release 21 September 2018 NZX Limited WELLINGTON WITHDRAWAL OF NOMINATION TruScreen Limited (NZAX: TRU) Cervical cancer technology company, TruScreen Limited (NZAX:TRU) announces that Ms Marie Ficarra has, for personal reasons, withdrawn her nomination for election as a director of the company at the Annual Meeting on 27 September 2018. As a result, Resolution 5 in the Notice of Meeting has been withdrawn and Marie will cease to be a director at the close of the Annual Meeting. The Board would like to acknowledge and thank Marie for her contribution to the Company during her time as a Director. Martin Dillon CEO -ENDS- For more information visit www.truscreen.com Contact Martin Dillon TruScreen Chief Executive Officer Email: martindillon@truscreen.com About TruScreen: TruScreen's real time cervical cancer technology utilises a digital wand which is placed on the surface of the cervix to measure electrical and optical signals from the surrounding tissue. A sophisticated proprietary algorithm framework distinguishes between normal and abnormal (cancerous and precancerous) tissue to identify precancerous change, or cervical intraepithelial neoplasia (CIN). A Single Use Sensor (SUS) is used for each patient to protect against cross-infection. End CA:00324235 For:TRU Type:MEETING Time:2018-09-21 16:37:24